newsfilter
← Latest News
GlobeNewswire·

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor